The present invention relates to an in vitro method for creating a viable connective tissue and/or osseous tissue obtained by tribological solicitations of a biological culture. It further relates to a viable connective tissue and/or osseous tissue susceptible to be obtained by said method as well as to the use of said method or viable connective tissue and/or osseous tissue to prepare a biological implant.

The present disclosure provides improved biomaterials extracted from fibrous meniscal cartilage (FMC). The materials are at least partially decellularized and enzyme treated to remove at least a portion of the elastin and blood vessels found in FMC. Such biomaterials can be employed as tissue scaffolds, such as in transplant procedures.

The present disclosure provides compositions which may be used as tissue engineering materials, and more particularly xylitol-doped citrate polymer compositions which may be useful as bone grafts.

The present disclosure relates to compressed bone compositions, bone implants, and variants thereof. The present disclosure also relates to methods of preparing compressed bone compositions, bone implants, and variants thereof. The present disclosure also relates to methods of using the bone compositions, bone implants and variants thereof.

The present invention relates to compressed bone-based products and methods to make the same. The maintained compressed state of the product serves to enhance the product's inherent osteoconductivity.

A composition for the treatment of wounds includes demineralized bone fibers (DBF) derived from allogeneic or xenogenic cortical bone and/or polymeric fibers made from resorbable and/or non-resorbable polymer, and the composition may also include an oxygen-generating material and/or an oxygen carrier.

A fibrous birth tissue composition fabricated from placental tissue is provided. Methods of processing a mammal's placental tissue to form a fibrous birth tissue composition are provided. Regenerative methods are also provided.

The disclosure provides bone graft materials, methods for their use and manufacture. Exemplary bone graft materials comprise combining a radiopaque component with a cancellous bone component to produce a bone graft material, wherein the cancellous bone component comprises native osteoreparative cells. Methods for treating a subject with the bone graft material are also provided.

A device for collecting a bone graft material comprises a canister extending defining a filter-receiving space therein, the canister including a connection for connecting to a vacuum source, a proximal end of the canister including a first locking feature and a filter element sized and shaped to be received within the filter-receiving space of the canister, the filter element including a channel extending therethrough, the channel defined via a mesh material and a proximal end of the filter element including a second locking feature releasably engageable with the first locking feature of the canister via a rotation of the filter element about a longitudinal axis thereof relative to the canister in combination with an extractor sized and shaped to be received within the channel of the filter element, the extractor defining a graft material receiving space therein and being releasably engageable with the extractor.

A bone gel composition consists of cortical bone. The cortical bone is made from cut pieces freeze-dried then ground into particles and demineralized then freeze-dried. A volume of the particles is placed in a solution of sterile water to create a mixture, the water volume being at least twice the particle volume, the mixture is autoclaved under heat and pressure to form a gelatin, the resulting bone gel is formed into sheets having a thickness (t).